FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/10/016219 [Registered on: 31/10/2018] Trial Registered Prospectively
Last Modified On: 30/10/2018
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Medical Device 
Study Design  Single Arm Study 
Public Title of Study   Use of non invasive brain stimulation to treat depression in adolescents. 
Scientific Title of Study   Use of Theta burst stimulation in adolescents with depression: Evaluating acceptability, safety, tolerability, and efficacy. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Siddhesh Shere 
Designation  Senior resident 
Affiliation  NIMHANS , Bangalore 
Address  405, New Kabini Annexe, Nimhans Hospital, Hosur Road
Nimhans Hospital, Hosur Road, near dairy circle, Banhgalore 560 029
Bangalore
KARNATAKA
560029
India 
Phone  9972640914   
Fax    
Email  siddhesh511@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sathish Girimaji 
Designation  Senior Professor 
Affiliation  NIMHANS , Bangalore 
Address  Adolescent psychiatry centre, 2nd floor, Nimhans Hospital, Hosur Road

Bangalore
KARNATAKA
560029
India 
Phone  9480829465  
Fax    
Email  drgirimaji@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Siddhesh Shere 
Designation  Senior resident 
Affiliation  NIMHANS , Bangalore 
Address  405, New Kabini Annexe, Nimhans Hospital, Hosur Road
Nimhans Hospital, Hosur Road, near dairy circle, Banhgalore 560 029

KARNATAKA
560029
India 
Phone  9972640914   
Fax    
Email  siddhesh511@yahoo.com  
 
Source of Monetary or Material Support  
NIMHANS HOSPITAL, Hombegowda nagar, Hosur road , Bangalore 560029 
 
Primary Sponsor  
Name  NIMHANS hospital 
Address  Hombegowda nagar , hosur road , near dairy circle , Bangalore 560 029 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
Dr Satish Girimaji  Dept of child and adolescent psychiatry , NIMHANS , Hombegowda nagar, Hosur road , Bangalore 560 029 
Dr Urvaksh Mehta  Dept of psychiatry , NIMHANS , Hombegowda nagar, Hosur road , Bangalore 560 029 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Siddhesh Shere  NIMHANS hospital  Adolescent psychiatry centre, 2nd floor, office room, Nimhans hospital, Hombegowda Nagar, Hosur road , near dairy circle, Bangalore 560 029
Bangalore
KARNATAKA 
9972640914

siddhesh511@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
NIMHANS ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F329||Major depressive disorder, singleepisode, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Not Applicable  Single arm  
Intervention  Theta Burst Stimulation (TBS)  TBS refers to a rTMS (repetitive transcranial magnetic stimulation) protocol where pulses are applied in bursts of three, delivered at a frequency of 50 Hz and an inter-burst interval of 200 ms (5 Hz) 
 
Inclusion Criteria  
Age From  12.00 Year(s)
Age To  18.00 Year(s)
Gender  Both 
Details  1. 12-18 years of age, either gender
2. Moderate – Severe Depression (as per DSM 5)
3. In patients in department of child & adolescent psychiatry,NIMHANS
4. Parents willing to consent for the study 
 
ExclusionCriteria 
Details  1. Intracranial implants (cochlear implants, aneurysmal clips)
2. Acute emergencies like high suicidal risk and catatonia where ECT is considered as a first line treatment
3. Current/Past history / family history of epilepsy
4. Adolescents on Methylphenidate , Bupropion , Clozapine, Tricyclic antidepressants
5. Active Neurological illness / head injury
6. Autism spectrum disorder , Intellectual developmental disorder
7. Organic mood disorders
8. Chronic physical illness 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To measure Adverse effect of TMS using structured tool devised by Pascal Leone , Visual analogue scale , Neuropsychological tests and rate of discontinuation  baseline , daily after TMS sessions , 1 week , 2 week , 3 month 
 
Secondary Outcome  
Outcome  TimePoints 
efficacy in terms of change in severity of depression over period of 12 weeks as measured by fall in CDRS-R scores  Baseline , 2 weeks , 3 months 
acceptability of TBS as a treatment modality as measured by ratio of those who accept TMS as treatment modality to those who were offered same  2 weeks 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/11/2018 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="1"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Shere, S., Subramanian, S., Bharath, S. & Purushottam, M. Lower levels of serum copper in patients with Alzheimer’s dementia: A controlled study from India. Asian Journal of Psychiatry 32, 73–74 (2018). Jayarajan, R.N., Shere, S., Sutar, R., Karmani, S., Reddi, V. S. K., Kesavan, M. , Viswanath, B. , Jain, S. (2014). Fluoxetine-induced pulmonary hypertension in a patient with schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences, 26, 4, E12-E13.  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   Primary purpose 
1) To study safety , tolerability and acceptance of TBS in adolescents with depression
2) To measure the efficacy of TMS as an add on to standard of care in adolescents with depression.

Hypothesis

1) TMS will be well tolerated by adolescents with minimal to none adverse effects and accepted by adolescents and their families
2) TMS will reduce severity of depression .
 
Close